This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Celgene Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations by Jennifer Almodovar Rodriguez
Introduction
Jennifer Almodovar Rodriguez is an accomplished inventor based in Cranford, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly through her innovative patent. Her work focuses on developing pharmaceutical compositions that have the potential to improve treatment options.
Latest Patents
Jennifer holds a patent for pharmaceutical compositions comprising (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile. This patent outlines methods of using these compositions, which include oral dosage formulations. The compositions consist of the active ingredient, along with a carrier or diluent, and provide a framework for preparing and utilizing these pharmaceutical innovations.
Career Highlights
Jennifer is currently associated with Celgene Corporation, where she continues to advance her research and development efforts. Her work has been instrumental in creating new therapeutic options that can benefit patients. With her expertise, she has contributed to the company's mission of improving health outcomes through innovative solutions.
Collaborations
Jennifer has collaborated with notable colleagues, including Shannon Higgins-Gruber and Demin Liu. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Jennifer Almodovar Rodriguez exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patent and work at Celgene Corporation highlight her commitment to advancing healthcare solutions. Her achievements serve as an inspiration for future inventors in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
